This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Skyline Therapeutics Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Qiongqiong Ren: Innovator in Gene Therapy
Introduction
Qiongqiong Ren is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of gene therapy, particularly through his innovative work on recombinant adeno-associated viruses.
Latest Patents
Ren holds a patent for a "Recombinant Adeno-Associated Virus with Modified AAV Capsid Polypeptides." This patent represents a crucial advancement in the development of gene therapy techniques, showcasing his expertise and commitment to innovation.
Career Highlights
Qiongqiong Ren is currently employed at Skyline Therapeutics Limited, where he continues to push the boundaries of genetic research. His work is instrumental in the ongoing development of therapies that could potentially transform treatment options for various genetic disorders.
Collaborations
Ren collaborates with esteemed colleagues, including Yanqun Shu and Jinzhao Hou. Their combined efforts contribute to the advancement of research in gene therapy and related fields.
Conclusion
Qiongqiong Ren's contributions to the field of gene therapy through his innovative patents and collaborative efforts highlight his role as a leading inventor in this vital area of research. His work continues to inspire advancements that may benefit countless individuals in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile